Brief: Aerovate Therapeutics Announces Third Quarter 2022 Financial Results

Jade Biosciences

14/11/2022 12:50

Nov 14 (Reuters) - Aerovate Therapeutics Inc  AVTE.O :
    * AEROVATE THERAPEUTICS ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS
    * AEROVATE THERAPEUTICS - EXPECT CASH, CASH EQUIVALENTS AND
SHORT-TERM INVESTMENTS WILL BE SUFFICIENT TO FUND OPERATIONS
INTO SECOND HALF OF 2025
    * QTRLY LOSS PER SHARE $0.56
    * CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED
$142.6
MILLION AS OF SEPTEMBER 30, 2022
    * Q3 EARNINGS PER SHARE VIEW $-0.50 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX24y5g8 
Further company coverage:  AVTE.O